A jury in a Philadelphia court on Friday ordered Bayer to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller.
(Reporting by Ludwig Burger, Editing by Rachel More)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.72 EUR | +0.47% | -2.06% | -14.44% |
08:23am | BAYER AG : JP Morgan reiterates its Neutral rating | ZD |
May. 17 | BAYER AG : UBS remains Neutral | ZD |
(Reuters) - Shares in Bayer opened 4.5% lower on Monday after the German company was ordered to pay $2.25 billion in damages, the highest amount yet in its ongoing litigation linked to an alleged carcinogenic effect of its Roundup weedkiller.
A jury in a Philadelphia court on Friday ordered Bayer to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller.
(Reporting by Ludwig Burger, Editing by Rachel More)
1st Jan change | Capi. | |
---|---|---|
-14.48% | 30.53B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.77% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |